Skip To Main Content
Jayne Pawasauskas on Muck Rack

Jayne Pawasauskas

As seen in: Practical Pain Management, TechTrends
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Jayne Pawasauskas’s profile

Articles by Jayne Pawasauskas

Hepatocyte Growth Factor as a Treatment for Diabetic Peripheral Neuropathy

|
By Jayne Pawasauskas, Kat Houlihan
| Practical Pain Management Verified
There is a current lack of treatment interventions for neuropathy and neuronal regeneration. VM202 presents a promising option for HGF agents as analgesics. By Kat Houlihan, PharmD Candidate and Jayne Pawasauskas, PharmD, BCPS Diabetic Peripheral Neuropathy Medications: A Background Diabetic peripheral neuropathy (DPN) is a progressive, quality of life-diminishing consequence of diabetes due to symptoms of debilitating pain and interference of sleep.
Open in Who Shared Issue with article?

Interleukin-17 Inhibitors

|
By Justin Jackson, Todd Brothers, Jayne Pawasauskas
| Practical Pain Management Verified
A comparison of the PsA disease-modifiers secukinumab, ixekizumab, and brodalumab as alternative treatment options to TNF-α and I-12/23 inhibitors, including for improving articular manifestations. Plus, how biologic DMARDs may be viewed as first-line options for improving PsA pain, function, and medication adherence.
Open in Who Shared Issue with article?

Analgesics of the Future: Inside the Potential of 3 Drug Delivery Systems

|
By Dmitry Arbuck, Jordan O'Leary, Jayne Pawasauskas
| Practical Pain Management Verified
A review of ZTlido (topical lidocaine), Zalviso and Dsuvia (sublingual sufentanil), and Wafermine (sublingual ketamine). By Jordan O'Leary, PharmD, Jayne Pawasauskas, PharmD, BCPS and Dmitry M. Arbuck, MD Pages 55-59 Overview For some patients, traditional oral or intravenous (IV) formulations may not be sufficient for pain control, come with undesirable adverse effects, or may not be clinically optimal. Therefore, alternative routes of delivery must be considered.
Open in Who Shared Issue with article?
Show More